Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Hypersensitivity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04921969
What this trial is testing

Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)

Who this might be right for
Atopic Dermatitis
Incyte Corporation 330
Testing effectiveness (Phase 2)Study completedNCT03903822
What this trial is testing

Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 292
Not applicableUnknownNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Testing effectiveness (Phase 2)Study completedNCT04021862
What this trial is testing

Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisEczema
Janssen Research & Development, LLC 87
Not applicableActive Not RecruitingNCT04798079
What this trial is testing

Systems Biology of Early Atopy

Who this might be right for
Allergic DiseasesFood AllergyAtopic Dermatitis
National Institute of Allergy and Infectious Diseases (NIAID) 2,500
Testing effectiveness (Phase 2)Study completedNCT01223222
What this trial is testing

Evaluate Safety, Tolerability and Efficacy of Lytixar™ (LTX-109) on Uncomplicated, Gram-positive, Skin Infection

Who this might be right for
Gram-positive, Skin InfectionsMild Eczema/DermatosesAtopic Dermatitis
Lytix Biopharma AS 24
Large-scale testing (Phase 3)Study completedNCT01467362
What this trial is testing

Efficacy Emollient on Xerosis in Children With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pierre Fabre Medicament 251
Testing effectiveness (Phase 2)Study completedNCT04992546
What this trial is testing

Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Principia Biopharma, a Sanofi Company 39
Testing effectiveness (Phase 2)Ended earlyNCT05911841
What this trial is testing

LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 234
Testing effectiveness (Phase 2)Study completedNCT01552629
What this trial is testing

A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 22
Not applicableWithdrawnNCT05006300
What this trial is testing

Evaluation of the Efficacy of Topialyse Baume barrière on Atopic Dermatis

Who this might be right for
Atopic Dermatitis
SVR Group
Not applicableLooking for participantsNCT07014007
What this trial is testing

Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks

Who this might be right for
Atopic Dermatitis
Pierre Fabre Dermo Cosmetique 105
Post-approval studies (Phase 4)WithdrawnNCT03710044
What this trial is testing

Investigation of Flare and Remission in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma
Not applicableUnknownNCT06498219
What this trial is testing

Optimization of the Skin Test Procedure With Iodinated Contrast Products for Certain Patients Suspected of Immediate Hypersensitivity

Who this might be right for
Contrast Sensitivity
University Hospital, Strasbourg, France 100
Not applicableStudy completedNCT01353807
What this trial is testing

Impact of Fish Oil Supplementation in 3rd Trimester of Pregnancy on Maternal and Offspring Health

Who this might be right for
Preterm DeliveryAtopyMetabolic Syndrome
Centre for Fetal Programming, Denmark 533
Large-scale testing (Phase 3)Ended earlyNCT05387707
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

Who this might be right for
PruritusAtopic Dermatitis
Cara Therapeutics, Inc. 287
Not applicableStudy completedNCT06427122
What this trial is testing

Effect of EMD Protocol for Urge on Dermatology-specific Quality of Life

Who this might be right for
Atopic DermatitisPrurigo Nodularis
Tamar Nijsten 96
Testing effectiveness (Phase 2)Looking for participantsNCT07330934
What this trial is testing

Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd. 403
Not applicableStudy completedNCT03931954
What this trial is testing

Prevalence of the Eosinophilic Phenotype Among Severe Asthma Patients

Who this might be right for
Severe Asthma
AstraZeneca 794
Large-scale testing (Phase 3)Study completedNCT03002571
What this trial is testing

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects (301)

Who this might be right for
Atopic Dermatitis
Bausch Health Americas, Inc. 338
Next Page